Open AccessAnticonvulsant Medications in Mitochondrial Disease
Author(s) -
Divakar S. Mithal,
Jonathan E. Kurz
Publication year - 2017
Publication title -
pediatric neurology briefs
Language(s) - English
Resource type - Journals
eISSN - 2166-6482
pISSN - 1043-3155
DOI - 10.15844/pedneurbriefs-31-3-3
Subject(s) - levetiracetam , mitochondrial disease , anticonvulsant , epilepsy , mitochondrion , pharmacology , convulsant , medicine , drug , disease , neuroscience , psychology , psychiatry , biology , mitochondrial dna , pathology , biochemistry , receptor , gene
Researchers from Vienna, Austria and Sao Paulo, Brazil studied the known effects of anticonvulsant drugs on mitochondria, using a literature search to include only references to epilepsy associated with mitochondrial disease, and a specific anti-convulsant drug (i.e. levetiracetam) with a specific mitochondrial function (i.e. mitochondrial membrane potential).